Getting Started

GLP-1 Prior Authorization on Medicare

Step-by-step guide to GLP-1 prior authorization under Medicare's 2026 Bridge program — what your doctor submits to CMS, timelines, denials, and appeals.

By Alan Jones · Last updated July 6, 2026

The short answer

For the Medicare GLP-1 Bridge, your doctor submits one prior authorization to a single CMS central processor — not to your own Part D plan — and once approved it stays valid through December 31, 2027.

Prior authorization ("PA") is the step where your prescriber proves to Medicare that you meet the rules before your $50 copay kicks in. The good news for the Bridge: it is more streamlined than an ordinary Part D prior authorization, because every request goes to the same place and is judged by the same uniform criteria. Not sure you qualify yet? Start with our 60-second eligibility quiz.

Who submits it, and to whom

You do not fill out the prior authorization — your prescribing doctor (or their office staff) does. And it does not go to your individual Part D plan the way most drug PAs do. For the Bridge, CMS uses a single central processor: Humana, the company that already administers Medicare's Limited Income Newly Eligible Transition (LI NET) program, handles prior authorization, claims, and pharmacy payment for the whole country. That is why your own plan does not need to "opt in" — the approval criteria are identical for every eligible Part D and Medicare Advantage drug plan member. (If you were looking for a paperwork form to complete yourself, see is there a Bridge form? — the short answer is no.)

What your doctor attests to

The prior authorization is an attestation against CMS's published criteria. Your doctor certifies that you are at least 18, that the GLP-1 is prescribed to reduce excess body weight alongside ongoing lifestyle changes (structured nutrition and physical activity), and that you meet one of three BMI tiers:

BMI 35 or higher — no additional condition required.
BMI 30 or higher — plus heart failure with preserved ejection fraction, uncontrolled high blood pressure (systolic over 140 or diastolic over 90 despite two BP medications), or chronic kidney disease stage 3a or above.
BMI 27 or higher — plus prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease.

A rule that surprises many people: the BMI that counts is your BMI at the time you started GLP-1 therapy, not today's. CMS's own example is a person who began therapy with a BMI of 37 and is now at 34 — they still qualify under the first tier. Full detail in conditions that lower your BMI threshold.

Note who the Bridge is not for: if your GLP-1 is prescribed for type 2 diabetes, moderate-to-severe sleep apnea, or MASH, those uses are covered by your regular Part D plan, so you would not use the Bridge at all.

How long it takes

Timing depends on how quickly your doctor's office submits and whether the request is marked urgent:

Standard review: typically up to 72 hours after submission.
Expedited review: up to 24 hours, when your doctor indicates it is urgent.
Realistically, start to finish: 2–4 weeks from your first appointment to a filled prescription, most of which is the time it takes to get in with your doctor and for the office to send the paperwork.

The first-fill rejection is normal

Here is the part that alarms people unnecessarily. On your first fill, the pharmacy claim is designed to be rejected before the prior authorization is completed — that rejection is the system flagging that your prescriber needs to finish the PA. It is not a denial. Once your doctor completes the prior authorization, the pharmacy re-runs the claim and the $50 copay applies. Bring our paperwork checklist to your appointment so nothing holds this up.

Get the drug and formulation right

A prior authorization can be approved and still fail at the counter if the prescription is for a product the Bridge does not cover. The Bridge covers all formulations of Wegovy (injection and tablets) and Foundayo, but only the KwikPen version of Zepbound — single-dose Zepbound pens and vials are excluded. If you are prescribed Zepbound, confirm it is written for the KwikPen. See which drugs the Bridge covers.

If it's denied

Most initial denials are fixable — a missing BMI note, an unclear qualifying-condition record, the wrong tier, or the wrong Zepbound formulation. Your doctor can add documentation and resubmit, and you also have formal Medicare appeal rights (starting with a redetermination request within 60 days). Walk through the specifics in common reasons the Bridge is denied and how to appeal a denial.

Who to call

Your doctor's office can reach the Medicare GLP-1 Bridge prescriber call center at 855-273-0102 (Mon–Fri, 8 a.m.–7 p.m. ET) for help with the PA process or to check a request's status.
You can call 1-800-MEDICARE (1-800-633-4227; TTY 1-877-486-2048) with questions about your eligibility or the status of a request.

Data note

Data as of July 2026, verified against the CMS.gov Medicare GLP-1 Bridge pages. Review timeframes can change and specific processing details are set by CMS — confirm current rules with your plan or 1-800-MEDICARE. This article is educational and is not medical advice.

Frequently asked questions

Who submits the GLP-1 prior authorization for Medicare?

Your prescribing doctor (or their staff) submits it — you do not. For the Bridge, it goes to a single CMS central processor run by Humana (the LI NET administrator), not to your individual Part D plan.

How long does Medicare's GLP-1 prior authorization take?

Standard review typically takes up to 72 hours; expedited review (when your doctor marks it urgent) up to 24 hours. From first appointment to filled prescription, plan on about 2–4 weeks including scheduling and paperwork time.

Why was my first pharmacy claim rejected?

A first-fill rejection is normal and is not a denial. It signals that your prescriber still needs to complete the prior authorization. Once they do, the pharmacy re-runs the claim and the $50 copay applies.

Does my Part D plan have to approve the prior authorization?

No. The Bridge runs through CMS's central processor, not your plan. Your plan does not approve, deny, or need to opt in, and the criteria are identical for all eligible Part D and MA-PD members.

What if my prior authorization is denied?

Most initial denials are fixable — a missing BMI note, an unclear qualifying condition, the wrong tier, or the wrong Zepbound formulation. Your doctor can add documentation and resubmit, and you have formal appeal rights starting with a redetermination within 60 days.

Traveling With GLP-1s: Storage and Flying →

How to travel with Wegovy, Ozempic, or Zepbound — TSA carry-on rules, refrigeration windows by drug, hot-car cautions, and a snowbird packing checklist.

Common Reasons the GLP-1 Bridge Is Denied →

The most common reasons a Medicare GLP-1 Bridge request is denied — from wrong drug formulation to conditions that route through Part D — and how to fix each.

Is There a Medicare GLP-1 Bridge Form? →

There is a form — but your doctor files it, not you. What the Medicare GLP-1 Bridge prior authorization form is, who submits it, and what you do instead.

Put it into practice

Check your coverage, find a prescriber, and plan your meals — all free.

Eligibility quiz →Find a provider →Meal planner →

← Back to all articles

GLP1 Almanac is an independent reference site. Articles are educational and are not medical advice. Always verify coverage details with your plan or Medicare.gov, and consult your doctor about your care.